evonetix

Little Chesterford, United Kingdom

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

$24.1M raised

Feb 2023

Series B

Top Investors

Civilization VenturesDCVCInnovate UKMorningsideForesite Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has evonetix raised?

evonetix has raised $24.1M in total funding. The most recent round was Series B. The last funding was announced in February 2023.

Who are evonetix's investors?

evonetix's investors include Civilization Ventures, DCVC, Innovate UK, Morningside, Foresite Capital.

Where is evonetix headquartered?

evonetix is headquartered in Little Chesterford, United Kingdom.

What does evonetix do?

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

What stage is evonetix at?

evonetix is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 7, 2023.

MLA

"evonetix — Funding & Investors." VCBacked, February 7, 2023, https://www.vcbacked.co/company/evonetix. Accessed June 4, 2026.

APA

VCBacked. (2023). evonetix — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/evonetix

Wikipedia (cite web)

{{cite web |title=evonetix — Funding & Investors |url=https://www.vcbacked.co/company/evonetix |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 7, 2023.